Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury
Alicia N. Rizzo, Saad Sammani, Adilene E. Esquinca, et al.
AJP Lung Cellular and Molecular Physiology (2015) Vol. 309, Iss. 11, pp. L1294-L1304
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Endothelial Responses in Sepsis
Jérémie Joffre, Judith Hellman, Can İnce, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 202, Iss. 3, pp. 361-370
Closed Access | Times Cited: 457
The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities
Fraser R. Millar, Charlotte Summers, Mark Griffiths, et al.
Thorax (2016) Vol. 71, Iss. 5, pp. 462-473
Open Access | Times Cited: 206
Integrin-Dependent Cell–Matrix Adhesion in Endothelial Health and Disease
Jurjan Aman, Coert Margadant
Circulation Research (2023) Vol. 132, Iss. 3, pp. 355-378
Open Access | Times Cited: 43
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
Monia Marchetti
Annals of Hematology (2020) Vol. 99, Iss. 8, pp. 1701-1707
Open Access | Times Cited: 132
Repurposing anticancer drugs for the management of COVID-19
Khalid El Bairi, Dario Trapani, Angelica Petrillo, et al.
European Journal of Cancer (2020) Vol. 141, pp. 40-61
Open Access | Times Cited: 83
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
Shahd Horie, Alistair Nichol, Emanuele Rezoagli, et al.
Intensive Care Medicine (2020) Vol. 46, Iss. 12, pp. 2265-2283
Open Access | Times Cited: 76
Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody
Hector Quijada, Tadeo Bermudez, Carrie L. Kempf, et al.
European Respiratory Journal (2020) Vol. 57, Iss. 5, pp. 2002536-2002536
Open Access | Times Cited: 71
Endothelial cell signaling and ventilator-induced lung injury: molecular mechanisms, genomic analyses, and therapeutic targets
Ting Wang, Christine Groß, Ankit A. Desai, et al.
AJP Lung Cellular and Molecular Physiology (2016) Vol. 312, Iss. 4, pp. L452-L476
Open Access | Times Cited: 74
Autophagy inhibitor 3-methyladenine protects against endothelial cell barrier dysfunction in acute lung injury
Spencer Slavin, Antony Leonard, Valerie Grose, et al.
AJP Lung Cellular and Molecular Physiology (2017) Vol. 314, Iss. 3, pp. L388-L396
Open Access | Times Cited: 70
Adipose-derived exosomes protect the pulmonary endothelial barrier in ventilator-induced lung injury by inhibiting the TRPV4/Ca2+ signaling pathway
Qian Yu, Daoxin Wang, Xiaoting Wen, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 318, Iss. 4, pp. L723-L741
Open Access | Times Cited: 54
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
Justin de Brabander, Erik Duijvelaar, Job R. Schippers, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2200780-2200780
Open Access | Times Cited: 29
Transient Receptor Potential Vanilloid 4 and Serum Glucocorticoid–regulated Kinase 1 Are Critical Mediators of Lung Injury in Overventilated MiceIn Vivo
Laura Michalick, Lasti Erfinanda, Ulrike Weichelt, et al.
Anesthesiology (2016) Vol. 126, Iss. 2, pp. 300-311
Closed Access | Times Cited: 52
Imatinib for COVID-19: A case report
Alejandro Morales‐Ortega, David Bello, Cristina Llarena‐Barroso, et al.
Clinical Immunology (2020) Vol. 218, pp. 108518-108518
Open Access | Times Cited: 45
The endothelium: gatekeeper to lung ischemia-reperfusion injury
Huy Q. Ta, Maniselvan Kuppusamy, Swapnil K. Sonkusare, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury
SunMi L. Palumbo, Yoon-Joo Shin, Kareem Ahmad, et al.
AJP Lung Cellular and Molecular Physiology (2017) Vol. 312, Iss. 3, pp. L297-L308
Open Access | Times Cited: 43
Parkin regulates lipopolysaccharide-induced proinflammatory responses in acute lung injury
Eleftheria Letsiou, Saad Sammani, Huashan Wang, et al.
Translational research (2016) Vol. 181, pp. 71-82
Closed Access | Times Cited: 41
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Semih Başçı, Naim Ata, Fevzi Altuntaş, et al.
Journal of Oncology Pharmacy Practice (2020) Vol. 26, Iss. 7, pp. 1676-1682
Open Access | Times Cited: 38
Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study
Reza Nejat, Ahmad Shahir Sadr
In Silico Pharmacology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Vascular Contribution to Lung Repair and Fibrosis
Nunzia Caporarello, Giovanni Ligresti
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 69, Iss. 2, pp. 135-146
Open Access | Times Cited: 12
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
Leila N. Atmowihardjo, Job R. Schippers, Erik Duijvelaar, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 12
Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System
Meredith J. Crane, Kayla Lee, Ethan S. FitzGerald, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 38
Absence of TNF-α enhances inflammatory response in the newborn lung undergoing mechanical ventilation
Harald Ehrhardt, Tina Pritzke, Prajakta Oak, et al.
AJP Lung Cellular and Molecular Physiology (2016) Vol. 310, Iss. 10, pp. L909-L918
Open Access | Times Cited: 34
Inflammation without Vascular Leakage. Science Fiction No Longer?
Niall C.J. Filewod, Warren L. Lee
American Journal of Respiratory and Critical Care Medicine (2019) Vol. 200, Iss. 12, pp. 1472-1476
Closed Access | Times Cited: 32
COVID-19 therapy: What weapons do we bring into battle?
Sinara Mônica Vitalino de Almeida, José Cleberson Santos Soares, Keriolaine Lima dos Santos, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 23, pp. 115757-115757
Open Access | Times Cited: 30
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J. Fritch, Angie L. Mordant, Thomas S.K. Gilbert, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 10, pp. 3159-3177
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top